Meta-analysis of placebo-arm dropouts in osteoporosis randomized-controlled trials and implications for nocebo-associated discontinuation of anti-osteoporotic drugs in clinical practice
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Meta-analysis of placebo-arm dropouts in osteoporosis randomized-controlled trials and implications for nocebo-associated discontinuation of anti-osteoporotic drugs in clinical practice
Authors
Keywords
-
Journal
OSTEOPOROSIS INTERNATIONAL
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-01-04
DOI
10.1007/s00198-022-06658-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Step‐by‐step diagnosis and management of the nocebo/drucebo effect in statin‐associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP)
- (2022) Peter E. Penson et al. Journal of Cachexia Sarcopenia and Muscle
- Treatment thresholds and minimal clinically important effect sizes of antiosteoporotic medication–Survey among physicians and lay persons in Germany
- (2022) Piet van der Keylen et al. PLoS One
- Prevalence and patterns of anti-osteoporotic drug use based on 2019 real-world nationwide data in Greece
- (2022) Maria P. Yavropoulou et al. Archives of Osteoporosis
- Nocebo/drucebo effect in statin-intolerant patients: an attempt at recommendations
- (2021) Peter E Penson et al. EUROPEAN HEART JOURNAL
- Side Effect Patterns in a Crossover Trial of Statin, Placebo, and No Treatment
- (2021) James P. Howard et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- SCOPE 2021: a new scorecard for osteoporosis in Europe
- (2021) John A. Kanis et al. Archives of Osteoporosis
- The mode of delivery and content of communication strategies used in mandatory and non-mandatory biosimilar transitions: a systematic review with meta-analysis
- (2021) Chiara Gasteiger et al. Health Psychology Review
- Increasing and dampening the nocebo response following medicine-taking: A randomised controlled trial
- (2021) Kate MacKrill et al. JOURNAL OF PSYCHOSOMATIC RESEARCH
- Nocebo-Prone Behavior Associated with SARS-CoV-2 Vaccine Hesitancy in Healthcare Workers
- (2021) Dimos D. Mitsikostas et al. Vaccines
- Placebo and Nocebo Effects
- (2020) Luana Colloca et al. NEW ENGLAND JOURNAL OF MEDICINE
- European Headache Federation recommendations for placebo and nocebo terminology
- (2020) Dimos D. Mitsikostas et al. JOURNAL OF HEADACHE AND PAIN
- Diarrhoea in Systemic Sclerosis Patients as a Nocebo Effect of Nintedanib
- (2020) Vasiliki-Kalliopi Bournia et al. EUROPEAN RESPIRATORY JOURNAL
- Real-world persistence and adherence with oral bisphosphonates for osteoporosis: a systematic review
- (2019) F Fatoye et al. BMJ Open
- Determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment: results of an expert group meeting organized by the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) and the International Osteoporosis Foundation (IOF)
- (2019) M. Hiligsmann et al. OSTEOPOROSIS INTERNATIONAL
- RoB 2: a revised tool for assessing risk of bias in randomised trials
- (2019) Jonathan A C Sterne et al. BMJ-British Medical Journal
- Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study
- (2018) Rishi J Desai et al. BMJ-British Medical Journal
- Differences in rates of switchbacks after switching from branded to authorized generic and branded to generic drug products: cohort study
- (2018) Rishi J Desai et al. BMJ-British Medical Journal
- Nocebos in rheumatology: emerging concepts and their implications for clinical practice
- (2018) Evrydiki Kravvariti et al. Nature Reviews Rheumatology
- A systematic review of factors affecting medication adherence among patients with osteoporosis
- (2018) C. T. Yeam et al. OSTEOPOROSIS INTERNATIONAL
- What is associated with increased side effects and lower perceived efficacy following switching to a generic medicine? A New Zealand cross-sectional patient survey
- (2018) Kate MacKrill et al. BMJ Open
- International Osteoporosis Foundation and European Calcified Tissue Society Working Group. Recommendations for the screening of adherence to oral bisphosphonates
- (2017) A. Diez-Perez et al. OSTEOPOROSIS INTERNATIONAL
- Subjective Complaints as the Main Reason for Biosimilar Discontinuation After Open-Label Transition From Reference Infliximab to Biosimilar Infliximab
- (2017) Lieke Tweehuysen et al. Arthritis & Rheumatology
- Examination of overall treatment effect and the proportion attributable to contextual effect in osteoarthritis: meta-analysis of randomised controlled trials
- (2016) Kun Zou et al. ANNALS OF THE RHEUMATIC DISEASES
- Real-Life and RCT Participants: Alendronate Users Versus FITs’ Trial Eligibility Criterion
- (2016) Carlen Reyes et al. CALCIFIED TISSUE INTERNATIONAL
- Osteoporosis medication dispensing for older Australian women from 2002 to 2010: influences of publications, guidelines, marketing activities and policy
- (2014) Geeske Peeters et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Using Sherlock and ClinicalTrials.gov Data to Understand Nocebo Effects and Adverse Event Dropout Rates in the Placebo Arm
- (2013) M. Soledad Cepeda et al. JOURNAL OF PAIN
- Placebo and Nocebo Effects in Randomized Controlled Trials: The Implications for Research and Practice
- (2013) Christine Sanderson et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Nocebo in clinical trials for depression: A meta-analysis
- (2013) Dimos D. Mitsikostas et al. PSYCHIATRY RESEARCH
- Determinants of patient adherence: a review of systematic reviews
- (2013) Przemyslaw Kardas et al. Frontiers in Pharmacology
- The Clinical and Economic Burden of Poor Adherence and Persistence with Osteoporosis Medications in Ireland
- (2012) Mickaël Hiligsmann et al. VALUE IN HEALTH
- Nocebo in fibromyalgia: meta-analysis of placebo-controlled clinical trials and implications for practice
- (2011) D. D. Mitsikostas et al. EUROPEAN JOURNAL OF NEUROLOGY
- Differing perceptions of intervention thresholds for fracture risk: a survey of patients and doctors
- (2011) F. Douglas et al. OSTEOPOROSIS INTERNATIONAL
- A reappraisal of generic bisphosphonates in osteoporosis
- (2011) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- A Meta-Analysis of Osteoporotic Fracture Risk with Medication Nonadherence
- (2011) Susan Ross et al. VALUE IN HEALTH
- Efficacy and safety of monthly ibandronate in men with low bone density
- (2010) Eric S. Orwoll et al. BONE
- Effects of bazedoxifene on bone mineral density, bone turnover, and safety in postmenopausal japanese women with osteoporosis
- (2010) Akira Itabashi et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Nocebo effects in multiple sclerosis trials: a meta-analysis
- (2010) D. Papadopoulos et al. Multiple Sclerosis Journal
- Relationship between compliance and persistence with osteoporosis medications and fracture risk in primary health care in France: A retrospective case—control analysis
- (2009) François-Emery Cotté et al. CLINICAL THERAPEUTICS
- The efficacy and tolerability of once-weekly alendronate 70 mg on bone mineral density and bone turnover markers in postmenopausal Chinese women with osteoporosis
- (2009) Yuxiang Yan et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Differences in persistence, safety and efficacy of generic and original branded once weekly bisphosphonates in patients with postmenopausal osteoporosis: 1-year results of a retrospective patient chart review analysis
- (2009) Johann D. Ringe et al. RHEUMATOLOGY INTERNATIONAL
- Efficacy and safety of monthly oral ibandronate in the prevention of postmenopausal bone loss
- (2008) Michael R. McClung et al. BONE
- Efficacy of Bazedoxifene in Reducing New Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis: Results From a 3-Year, Randomized, Placebo-, and Active-Controlled Clinical Trial*
- (2008) Stuart L Silverman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Once-Weekly Risedronate in Men With Osteoporosis: Results of a 2-Year, Placebo-Controlled, Double-Blind, Multicenter Study
- (2008) Steven Boonen et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Once-Monthly Oral Ibandronate Improves Biomechanical Determinants of Bone Strength in Women with Postmenopausal Osteoporosis
- (2008) E. Michael Lewiecki et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started